The GSVA findings (S3 Fig) indicate that the downregulation of the TSPO gene in AD is linked to pathological mechanisms such as inflammatory responses, neurodegeneration, metabolic disorders, and immune abnormalities. The gene discussed is TSPO; the disease is Alzheimer disease.